Staff Profiles: Dr. Lee Potiphar

Image is unavailable

Staff Profile: Dr. Lee Potiphar
Senior Lecturer in Adult Nursing

Image is unavailable

Dr. Lee Potiphar

Senior Lecturer in Adult Nursing

Allied Health Professions

Nursing

Previously a Senior Research Nurse, I am passionate about passing on my knowledge and experience to improve the future of healthcare.

Biography

Now a lecturer in Adult Nursing, and senior tutor for Nursing, I previously carried out research as a Senior Research Nurse and was a Trial Manager running large multi-site studies. I now teach clinical management and the third-year dissertation.

I spent three years at the University of Oxford as a Band 8a Trial Manager, running an oncology Clinical Trial of an Investigative Medicinal Product (CTIMP) looking into myeloproliferative neoplasms. Before this, I worked at Imperial Collage London as a Band 7 Senior Research Nurse, in charge of a team of Band 6 Clinical Research Nurses. Our research studies included active/latent TB and HIV.

I am also Chair of an NHS Research Ethics Committee (REC).

I am passionate about teaching nursing, and passing on my knowledge and experience to improve the future of nursing and healthcare.

Accreditation

BSc, MSc, PGCE, PGCertHE, PhD

Awards

Shortlisted for Inspirational Teacher of the Year (Birmingham City University) for 2019/2020.

Membership of professional bodies

Nursing and Midwifery Council

Teaching and research

Teaching

My teaching focusses on: Leading & Managing Care Within the Multi-Disciplinary Team; Leading and Managing Care in Practice and Driving Change and Innovation.

Level

Undergraduate

Research

I have three areas of research: Diabetes (type I & II) – both adult and paediatric participants. A range of intervention, diagnostic and educational studies. Respirator medicine – adult participants. Diagnostic studie?s, mainly comprising TB (active/latent) and HIV-TB co-infection. Haematology – adult participants. Main study a Simon Stage II, phase II clinical trial of an IMP (Investigative Medicinal Product) for patients with myelofibrosis about to undertake a reduced intensity allogenic cell transplant as a curative measure.

Publications